1 |
Yanagida, K., Kurikawa, Y., Shimizu, T. and Ishii, S. (2013) Current progress in non-Edg family LPA receptor research. Biochim. Biophys. Acta 1831, 33-41.
DOI
ScienceOn
|
2 |
Makide, K., Kitamura, H., Sato, Y., Okutani, M. and Aoki, J. (2009) Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol. Prostaglandins Other Lipid Mediat. 89, 135-139.
DOI
|
3 |
Misra, U. K. (1965) Isolation of lysophosphatidylethanolamine from human serum. Biochim. Biophys. Acta 106, 371-378.
DOI
|
4 |
Nishina, A., Kimura, H., Sekiguchi, A., Fukumoto, R. H., Nakajima, S. and Furukawa, S. (2006) Lysophosphatidylethanolamine in Grifola frondosa as a neurotrophic activator via activation of MAPK. J. Lipid Res. 47, 1434-1443.
DOI
|
5 |
Park, K. S., Lee, H. Y., Kim, M. K., Shin, E. H. and Bae, Y. S. (2005) Lysophosphatidylserine stimulates leukemic cells but not normal leukocytes. Biochem. Biophys. Res. Commun. 333, 353-358.
DOI
|
6 |
Park, K. S., Lee, H. Y., Kim, M. K., Shin, E. H., Jo, S. H., Kim, S. D., Im, D. S. and Bae, Y. S. (2006) Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G proteins. Mol. Pharmacol. 69, 1066-1073.
|
7 |
Park, K. S., Lee, H. Y., Lee, S. Y., Kim, M. K., Kim, S. D., Kim, J. M., Yun, J., Im, D. S. and Bae, Y. S. (2007) Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor. FEBS Lett. 581, 4411-4416.
DOI
|
8 |
Park, S. J., Lee, K. P., Kang, S., Chung, H. Y., Bae, Y. S., Okajima, F. and Im, D. S. (2013) Lysophosphatidylethanolamine utilizes and CD97 in MDA-MB-231 breast cancer cells. Cell. Signal. 25, 2147-2154.
DOI
|
9 |
Ritscher, L., Engemaier, E., Staubert, C., Liebscher, I., Schmidt, P., Hermsdorf, T., Rompler, H., Schulz, A. and Schoneberg, T. (2012) The ligand specificity of the G-protein-coupled receptor GPR34. Biochem. J. 443, 841-850.
DOI
ScienceOn
|
10 |
Sugo, T., Tachimoto, H., Chikatsu, T., Murakami, Y., Kikukawa, Y., Sato, S., Kikuchi, K., Nagi, T., Harada, M., Ogi, K., Ebisawa, M. and Mori, M. (2006) Identification of a lysophosphatidylserine receptor on mast cells. Biochem. Biophys. Res. Commun. 341, 1078-1087.
DOI
ScienceOn
|
11 |
Swaney, J. S., Chapman, C., Correa, L. D., Stebbins, K. J., Broadhead, A. R., Bain, G., Santini, A. M., Darlington, J., King, C. D., Baccei, C. S., Lee, C., Parr, T. A., Roppe, J. R., Seiders, T. J., Ziff, J., Prasit, P., Hutchinson, J. H., Evans, J. F. and Lorrain, D. S. (2011) Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. J. Pharmacol. Exp. Ther. 336, 693-700.
DOI
ScienceOn
|
12 |
Iwashita, M., Makide, K., Nonomura, T., Misumi, Y., Otani, Y., Ishida, M., Taguchi, R., Tsujimoto, M., Aoki, J., Arai, H. and Ohwada, T. (2009) Synthesis and evaluation of lysophosphatidylserine analogues as inducers of mast cell degranulation. Potent activities of lysophosphatidylthreonine and its 2-deoxy derivative. J. Med. Chem. 52, 5837-5863.
DOI
ScienceOn
|
13 |
Chang, Y. J., Lee, Y. K., Lee, E. H., Park, J. J., Chung, S. K. and Im, D. S. (2006) Structure-activity relationships of dimethylsphingosine (DMS) derivatives and their effects on intracellular pH and in the U937 monocyte cell line. Arch. Pharm. Res. 29, 657-665.
과학기술학회마을
DOI
|
14 |
Choi, J. W. and Chun, J. (2013) Lysophospholipids and their receptors in the central nervous system. Biochim. Biophys. Acta 1831, 20-32.
DOI
ScienceOn
|
15 |
Inoue, A., Ishiguro, J., Kitamura, H., Arima, N., Okutani, M., Shuto, A., Higashiyama, S., Ohwada, T., Arai, H., Makide, K. and Aoki, J. (2012) TGFa shedding assay: an accurate and versatile method for detecting GPCR activation. Nature methods 9, 1021-1029.
DOI
ScienceOn
|
16 |
Jo, S. H., Kim, S. D., Kim, J. M., Lee, H. Y., Lee, S. Y., Shim, J. W., Yun, J., Im, D. S. and Bae, Y. S. (2008) Lysophosphatidylglycerol stimulates chemotactic migration in human natural killer cells. Biochem. Biophys. Res. Commun. 372, 147-151.
DOI
|
17 |
Kitamura, H., Makide, K., Shuto, A., Ikubo, M., Inoue, A., Suzuki, K., Sato, Y., Nakamura, S., Otani, Y., Ohwada, T. and Aoki, J. (2012) GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position. J. Biochem. 151, 511-518.
DOI
ScienceOn
|
18 |
Lee, S. Y., Lee, H. Y., Kim, S. D., Jo, S. H., Shim, J. W., Lee, H. J., Yun, J. and Bae, Y. S. (2008) Lysophosphatidylserine stimulates chemotactic migration in U87 human glioma cells. Biochem. Biophys. Res. Commun. 374, 147-151.
DOI
|
19 |
Makide, K. and Aoki, J. (2013) GPR34 as a lysophosphatidylserine receptor. J. Biochem. 153, 327-329.
DOI
ScienceOn
|
20 |
Liebscher, I., Muller, U., Teupser, D., Engemaier, E., Engel, K. M., Ritscher, L., Thor, D., Sangkuhl, K., Ricken, A., Wurm, A., Piehler, D., Schmutzler, S., Fuhrmann, H., Albert, F. W., Reichenbach, A., Thiery, J., Schoneberg, T. and Schulz, A. (2011) Altered immune response in mice deficient for the G protein-coupled receptor GPR34. J. Biol. Chem. 286, 2101-2110.
DOI
ScienceOn
|
21 |
Ahn, B. R., Moon, H. E., Kim, H. R., Jung, H. A. and Choi, J. S. (2012) Neuroprotective effect of edible brown alga Eisenia bicyclis on amyloid peptide-induced toxicity in PC12 cells. Arch. Pharm. Res. 35, 1989-1998.
과학기술학회마을
DOI
ScienceOn
|
22 |
Castelino, F. V., Seiders, J., Bain, G., Brooks, S. F., King, C. D., Swaney, J. S., Lorrain, D. S., Chun, J., Luster, A. D. and Tager, A. M. (2011) Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum. 63, 1405-1415.
DOI
ScienceOn
|